Effects of Epigallocatechin Gallate on Diabetes and Insulin Resistance
Author Information
Author(s): Yurtseven Kübra, Yücecan Sevinç
Primary Institution: Lokman Hekim University
Hypothesis
This study evaluates the potential effects of epigallocatechin gallate (EGCG) on the prognosis of diabetes and insulin resistance.
Conclusion
EGCG may be an effective component in the treatment of diabetes and management of insulin resistance, particularly at high doses.
Supporting Evidence
- EGCG significantly lowered fasting blood glucose levels, especially at high doses.
- At doses of 100 mg/kg and 200 mg/kg, EGCG improved insulin resistance and beta cell function.
- EGCG was found to increase insulin secretion and improve insulin sensitivity.
Takeaway
This study found that a compound in green tea called EGCG can help lower blood sugar and improve insulin function in diabetic rats.
Methodology
The study used 35 male Wistar albino rats, inducing diabetes with streptozotocin and administering different doses of EGCG to evaluate its effects on metabolic parameters.
Potential Biases
Potential bias in the selection of animal models and the administration of treatments.
Limitations
The study was conducted on rats, and results may not directly translate to humans.
Participant Demographics
35 male Wistar albino rats, aged 8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website